Revenue (Tables)

12 Months Ended

Sep. 30, 2023

The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:


		Years Ended
		September 30, 2023						September 24, 2022						September 25, 2021
Business (in millions)		United States		Intl.		Total		United States		Intl.		Total		United States		Intl.		Total
Diagnostics:
	Cytology & Perinatal	$	297.4	$	183.2	$	480.6	$	300.4	$	174.3	$	474.7	$	304.6	$	169.3	$	473.9
	Molecular Diagnostics	1,061.0		300.7		1,361.7		1,694.5		816.9		2,511.4		2,038.9		1,132.6		3,171.5
	Blood Screening	37.8		—		37.8		32.4		—		32.4		49.6		—		49.6
Total		1,396.2		483.9		1,880.1		2,027.3		991.2		3,018.5		2,393.1		1,301.9		3,695.0

Breast Health:
	Breast Imaging	884.0		260.2		1,144.2		735.1		216.5		951.6		830.4		253.0		1,083.4
	Interventional Breast Solutions	232.6		55.9		288.5		222.1		54.1		276.2		221.4		47.5		268.9

Total		1,116.6		316.1		1,432.7		957.2		270.6		1,227.8		1,051.8		300.5		1,352.3

GYN Surgical		475.3		128.9		604.2		423.8		99.1		522.9		396.4		91.7		488.1

Skeletal Health		69.9		43.5		113.4		59.6		34.0		93.6		61.0		35.9		96.9


Total		$	3,058.0	$	972.4	$	4,030.4	$	3,467.9	$	1,394.9	$	4,862.8	$	3,902.3	$	1,730.0	$	5,632.3


	Years Ended
Geographic Regions (in millions)		September 30, 2023		September 24, 2022		September 25, 2021
United States		$	3,058.0	$	3,467.9	$	3,902.3
Europe		520.3		888.5		1,201.8
Asia-Pacific		255.7		359.7		365.0
Rest of World		196.4		146.7		163.2
		$	4,030.4	$	4,862.8	$	5,632.3

The following table provides revenue recognized by source:


	Years Ended
Revenue by type (in millions)		September 30, 2023		September 24, 2022		September 25, 2021
Disposables		$	2,539.4	$	3,603.6	$	4,198.2
Capital equipment, components and software		740.5		587.6		769.1
Service		730.5		652.4		598.1
Other		20.0		19.2		66.9
		$	4,030.4	$	4,862.8	$	5,632.3